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August 4, 2009:573–6on’t Throw the Baby
ut With the Bath Water
udoff et al. (1) have presented important information from the
ESA (Multi-Ethnic Study of Atherosclerosis) trial about the
nterpretation of coronary artery calcium (CAC) scores. There has
een some controversy as to how to interpret what constitutes a
igh-risk score. Is the age/sex/ethnicity adjusted percentile score or
he absolute total score best? To me it seems to depend on what is
our question about high risk. In the Budoff et al. (1) article, clearly
he authors are interpreting high risk as the risk for a cardiac event
n the short term (46 months). However, to the clinician and
atient, it is of great importance to determine which individuals
re at high risk in the longer term (i.e., decades).
The authors cite an example of a 50-year-old Hispanic woman
ho has a CAC score of 25, which places her in the 95th percentile
or age/sex/ethnicity compared with an 83-year-old white man
ith a CAC of 1,572, which places him in the 72nd percentile for
is age/sex/ethnicity. The main point of the article is that although
he man has a lower percentile than the woman, he is at much
reater risk for a short-term cardiac event. No argument, the
reater the atherosclerotic burden the greater the short-term risk.
owever, I think it is important to recognize that the percentile
core has clinically useful information that the absolute score does
ot. The fact that the 50-year-old woman’s score places her in the
5th percentile for age/sex/ethnicity means she will reach the
igh-risk score of 400 at a much earlier age, probably within 15
ears (2), compared with many of her peers, who had the more
ikely score of 0 and will take 35 years or longer to achieve a
igh-risk score. I believe this is very useful information for the
hysician and the patient and will significantly impact decision-
aking about diet, lifestyle, and medications. In other words, I
hink we and our patients are interested in both the short- and
ong-term risk. If I am a 39-year-old white man with a score of 50,
certainly would want to know that I am likely to have a high-risk
core within 10 years (3).
Knowing both short- and long-term risk is useful. The percen-
ile score predicts the long-term risk and tells us how soon,
ntreated, we will reach a high-risk score. The absolute score
epresents the atherosclerotic burden currently present and there-
ore best predicts the short-term risk.
However, the Budoff et al. (1) article and the accompanying
ditorial seem to downplay the importance and value of the
ercentile score in their enthusiasm to identify the most powerful
redictor of short-term risk. The data presented support their
nthusiasm, but please don’t throw the baby out with the bath
ater.
Bruce H. Brundage, MD
Medical Director
eard Institute of the Cascades
500 N.E. Neff Road
end, Oregon 97701
-mail: Bhbrundage@cascadehealthcare.orgdoi:10.1016/j.jacc.2009.02.083 CEFERENCES
. Budoff MJ, Nasir K, McClelland RL, et al. Coronary calcium predicts
events better with absolute calcium scores than age-sex-race/ethnicity
percentiles: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll
Cardiol 2009;53:345–52.
. McClelland RL, Chung H, Detrano R, Post W, Kronmal. Distribution
of coronary artery calcium by race, gender and age: results from the
Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2006;113:
30–7.
. Hoff JA, Chomka EV, Kranik AJ, Daviglus M, Rich S, Kondos GT.
Age and gender distributions of coronary artery calcium detected by
electron beam tomography in 35,246 adults. Am J Cardiol
2001;87:1335–9.
eply
e completely agree with Dr. Brundage’s supposition that a more
mportant marker for treatment targets may be lifetime risk. Data
uggest that 67% of men and 50% of women over 40 years of age
ill develop chronic heart disease (1). The concept of lifetime risk
as highlighted in the National Cholesterol Education Program
dult Treatment Panel III guidelines (2) and is especially impor-
ant for individuals who are young to middle-aged.
However, most data with risk factors, C-reactive protein, and
oronary artery calcium (CAC) have shorter-term follow-up and
nable clinicians to match intensity of therapy to intensity of risk
or near-term events. Lifetime lipid treatment or other antiathero-
clerotic therapies may start shifting cost benefits and possibly even
isk benefits away from treatment strategies.
Dr. Brundage correctly points out that while absolute scores are
etter short-term predictors, we cannot completely forgo percen-
ile scores. From our standpoint, presence of “any” CAC, irrespec-
ive of percentile, especially in younger individuals is an indicator
f significant intermediate-term and lifelong risk. The issues with
sing “only” percentiles for risk assessment pose problems at 2
evels. First, at each age group, women presenting with the same
evel of CAC scores as men are less likely to be considered as high
isk and, thus, to be treated. Second, another risk of using the
ercentile scores is underestimation of risk, and, thus, there is
otential for undertreatment of those persons with higher scores.
ersons with scores as high as 1,500 may be deemed “normal” by
ge and sex cutpoints, but clearly have at least a 20-fold increased
isk of future cardiovascular events (3). As participants with
aseline calcium scores are followed up to 12 years, risk continues
o diverge based upon baseline score, supporting the concept that
AC is a good predictor of lifetime risk (4).
One limitation of the MESA (Multi-Ethnic Study of Athero-
clerosis) study is that there were no persons under age 45 years, so
eally assessing younger patients with advanced atherosclerosis is
utside the scope of our study. Younger patients especially need to
ely more heavily on percentile scores, as they rarely achieve scores
100, yet may be at increased risk. Taylor et al. (5) prospectively
ollowed 2,000 persons (mean age 43 years) for 3 years, and the
resence of any plaque was associated with an 11.8-fold increased
isk of a cardiovascular event (5). Using a percentile to give patients
relative place compared with their age, sex, and ethnic/racial
eers allows physicians to treat patients who are “ahead of the
urve” with increased vascular age. By emphasizing both absolute
nd percentile scores, we can identify those at higher risk of
ifelong cardiovascular disease by acknowledging presence of any
AC as a marker of subclinical disease.
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linical Significance of Iodine-123
etaiodobenzylguanidine
ardiac Imaging
n a recent issue of the Journal, Tamaki et al. (1) found that in their
tudy sample of 106 consecutive patients with stable congestive
eart failure (CHF), those experiencing a sudden cardiac death
SCD) had on average a higher washout rate of iodine-123
etaiodobenzylguanidine (MIBG WR) compared with those who
urvived. Statistically, the cardiac MIBG WR was a powerful
redictor of SCD in patients with mild-to-moderate CHF. But
ow can this best be applied clinically?
The mean (X1) washout rate in those with SCD was 39.9%
ith a standard deviation (SD1) of 15.2%. For those without
CD, the mean (X2) washout rate was 27.6% with a standard
eviation (SD2) of 14.2%. Using this data, we can determine the
rossover point below which a patient is more likely than not to fall
nto the low-risk group (no SCD) and above which a patient is
ore likely than not to fall into the high-risk group (SCD) (2).
The crossover point (CP)  (SD1 · X2  SD2 · X1)/(SD1 
D2)  33.5%. This CP falls 0.42 SDs above X2 and 0.42 SDs
elow X1 (i.e., X2 0.42 · SD2 X1 0.42 · SD1). In normally
istributed data, using a z-score table, we find that, at best, 34% of
he patients will be miscategorized when using the MIBG WR iffixed threshold value is utilized. If we use a threshold of 27%, as
roposed by Ogita et al. (3), then over 50% of the low-risk patients
ill be miscategorized. Threshold values either above or below the
P will only lead to a miscategorization rate 34%.
In clinical practice, fixed threshold values for continuous data
uch as the MIBG WR are not rigidly followed. Patients are
requently categorized as “borderline normal” or “borderline ab-
ormal.” Are there better ways to make sense of the data so it can
e more clinically useful? Simply reporting the means, SDs, and a
hreshold value does not adequately characterize the data for the
linician caring for an individual patient.
We propose that a more useful way to report continuous
ariables that impact patient care is to give at least 3 reference
alues: 1) the point where an individual patient is just as likely as
ot to belong to group 1 as to group 2; 2) the odds of belonging
o group 1 at X1; and 3) the odds of belonging to group 2 at X2.
n some situations, additional reference values may be useful. For
he MIBG WR data, the CP  33.5%. This is the point at which
he odds are 50/50 in regard to whether the patient is in the
igh-risk or in the low-risk group. The formula to determine this
oint is given in the preceding text.
When a patient’s MIBG WR is 39.9% or greater, the odds are
t least 2.6 to 1 that the patient is in the high-risk group. This is
alculated by finding the z-score of the absolute value of (X1 
2)/SD2, then dividing 0.5 by the area under the curve to the right
f this z-score. When a patient’s MIBG WR is 27.6% or less, the
dds are at least 2.4 to 1 that the patient is in the low-risk group.
his is calculated by finding the z-score of the absolute value of
X1  X2)/SD1, then dividing 0.5 by the area under the curve to
he right of this z-score.
This type of numerical summary helps clinicians reasonably
pply and explain the MIBGWR to individual patients with stable
HF. When a patient’s MIBG WR is around 33%, the test does
ot help categorize the patient into a low- or high-risk category (a
oin flip is just as accurate). However, when the MIBG WR is
7% or less, the odds are greater than 2:1 that the patient is at low
isk. When the MIBG WR is 40% or higher, the odds are greater
han 2:1 that the patient is at high risk. Basing medical manage-
ent upon MIBG WR values between 30% and 36% is basically
ust guessing, and will lead to suboptimal care in a high percentage
f patients.
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